CTRI/2009/091/000676
Other
未知
Prevalence of atherosclerotic disease in Asian subjects not on lipid-lowering agents, but with at least two CVD risk factors
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AstraZeneca
- Enrollment
- 3150
- Status
- Other
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with at least two CVD risk factors but not on lipid\-lowering agents
- •\- Provision of signed informed consent.
Exclusion Criteria
- •\- Subjects with CHD, any conditions that may affect hs\-CRP levels.
- •\- Subjects on any lipid\-lowering drug treatment within the last 3 months prior study entry.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Mediators of Atherosclerosis in South Asians Living in AmericaAtherosclerosisCardiovascular DiseasesHeart DiseasesCoronary Artery DiseaseCoronary DiseaseNCT01207167University of California, San Francisco2,314
Completed
Not Applicable
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering DrugsCardiovascular DiseaseNCT00970918AstraZeneca2,609
Withdrawn
Not Applicable
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian IndiansHealthyNCT01104597Northwell Health
Not yet recruiting
Not Applicable
A study to assess the cardiovascular disease risk in Indian patientsCTRI/2024/02/062577Sun Pharma Laboratories Ltd.
Recruiting
Not Applicable
Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~JPRN-UMIN000038451Toyohashi Heart Center800